Abstract: Giant cell arteritis (GCA) requires a prompt diagnosis to avoid significant morbidity among the elderly. An accurate diagnosis is also paramount given the side effect profile of long-term corticosteroid treatment. Temporal artery biopsy (TAB) has long remained the gold standard for the diagnosis of GCA but requires an invasive procedure that is not without risk. This article discusses the argument for and against the use of noninvasive imaging including ultrasound, magnetic resonance imaging, and positron emission tomography scanning for the diagnosis of GCA. It also provides a suggested diagnostic algorithm for when to consider noninvasive imaging versus TAB.
nonophthalmic, noninvasive testing versus TAB in the diagnosis of GCA.
ARGUMENTS IN SUPPORT OF NONINVASIVE IMAGING Temporal Artery Biopsy Concerns
Although TAB has remained the gold standard for diagnosis of GCA for many years and is typically well tolerated, severe complications can rarely occur, including damage to the facial nerve, skin necrosis, brow ptosis, mistakenly removing a vein or a nerve, and stroke. 10, 11 In some cases, patients refuse to have the procedure. Furthermore, TAB may require suspension of anticoagulation, which presents both a logistical challenge and potential systemic health concerns. 7 It is also time consuming and can involve the use of costly resources when performed in an operating room setting. 7 Often, GCA exhibits skip lesions (regions of normal artery interspersed with regions of inflammation), which can contribute to a false negative biopsy, particularly in specimens less than 2 cm in length. 2, 7, 12, 13 Because of the protean, nonspecific presenting features of GCA, it is often considered and tested for in patients who ultimately do not have the disease. As a result, TAB is only abnormal in a small percentage of total biopsies but subjects many patients without the disease to potential procedural complications. 7 Bowling and colleagues 14 reported that of the 129 TABs performed in their study, almost 80% were negative, and the glucocorticoid regimen was modified in only 7.8% of these cases. In 10-30% of GCA patients, TAB fails at diagnosis when the region of inflammation is missed or nonarterial tissue is sampled. 15 Additionally, TAB is less sensitive in GCA patients with large vessel vasculitis (LVV) who lack temporal arteritis. 16 Therefore, if the clinical suspicion is high, patients will often be treated for GCA even with negative TABs.
The Case for Ultrasound
In 1995, Schmidt and colleagues 17 first reported a "hypoechoic halo" (Fig. 1) as a finding of GCA on Doppler ultrasound (US), believed to represent inflammation of the vessel wall. The reported diagnostic accuracy of the halo sign and other ultrasonographic findings of GCA, including stenosis and occlusion, varies among studies. Schmidt's initial report 17 described that all patients with GCA demonstrated a hypoechoic halo, which resolved within 2 weeks after initiation of corticosteroid treatment. A subsequent study by this group found that the halo sign had a sensitivity and specificity of 73% and 100%, respectively. 10 When combined with other US findings indicative of arteritis including stenosis or occlusion, the sensitivity of duplex US testing increased to 93% and the specificity remained high at 93%. 10 When compared with histologic evidence of arteritis from TAB, the presence of vascular halo, stenosis, or occlusion had a reported sensitivity and specificity of 95% and 85%, respectively. 10 More recently, a meta-analysis of 8 studies and 605 patients found that US had a pooled sensitivity and specificity of 77% and 96%, respectively, relative to a clinical diagnosis of GCA. 18 Thus, it may be that patients with classic clinical signs indicating a high pretest probability for GCA and a definite halo on US could be treated for GCA without a biopsy. 10, 18 In 2017, Schäfer and colleagues 19 reported threshold values of intima-media thickness to help standardize the process of differentiating affected from normal arteries in patients undergoing US examination for GCA workup.
The halo sign persists for a mean duration of 16 days (range, 7-56 days) after initiation of corticosteroid treatment. 10, 13, 15, 17 The European League Against Rheumatism (EULAR) likewise reported resolution of the halo sign after 2 to 4 weeks of steroid treatment. 18 Similar to the currently accepted clinical practice regarding the initiation of steroids before TAB, in the presence of high clinical suspicion of GCA, corticosteroid treatment can probably be initiated immediately without affecting the diagnostic yield of a subsequent confirmatory US if performed in this time frame. Other potential applications of US include structural confirmation of disease response during treatment and early identification of GCA recurrence, but further studies are needed to elucidate the expected appearance of US findings at particular time points after initiation of glucocorticoid treatment. 15, 20, 21 The compression sign, defined as the continued visibility of hypoechoic temporal artery wall thickening during US probeinduced pressure over the vessel, is another robust diagnostic marker of GCA with reported sensitivities of 77-79% and a specificity of 100%. 18 The compression sign has been shown to have good interobserver agreement. 21 Ultrasound findings of increased flow velocity and turbulence have also been proposed as indicators of vasculitis. Additionally, the diagnostic value of US in GCA patients may be enhanced by including US examination of the axillary arteries in addition to the temporal arteries. 21 Implementation of a GCA US protocol necessitates a multidisciplinary approach among rheumatology, neurology, ophthalmology, general surgery, vascular surgery, and radiology.
7 Some additional procedural training is necessary for duplex US technicians, though their extensive preexisting knowledge of vascular imaging has been shown to facilitate successful adoption of the test.
7 Despite the small sample size, the fast-track clinic model introduced by Diamantopoulos and colleagues 22 reduced the risk of permanent vision loss in GCA patients while simultaneously reducing costs, suggesting it may be a sustainable model that improves patient care. 23 In summary, US imaging is noninvasive, does not require cessation of anticoagulation, and is quicker and less costly than TAB.
7 Utilization of US and TAB need not be mutually exclusive. One major advantage of US testing is that it allows for noninvasive evaluation of the entire length of the bilateral superficial temporal arteries and the ability to image the axillary arteries and supra-aortic vessels. 13, 18, 21, 22 In situations where TAB is deemed necessary, US can localize vascular inflammation and direct the surgeon to perform a targeted biopsy, thereby improving the biopsy sensitivity. 24 
The Case for Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) has also been investigated as a noninvasive imaging modality for the diagnosis of GCA. Mural contrast enhancement and arterial wall thickening are established MRI findings that suggest the presence of acute inflammation 6, 25 ( Fig. 2) . High-resolution MRI using advanced coil designs capture images with submillimeter resolution. 4 Furthermore, MRI shows the entire cranial circumference, allowing identification of skip lesions in the temporal arteries or capturing evidence of inflammation involving other extracranial arteries such as the occipital artery. 4 According to a EULAR meta-analysis, arterial wall enhancement of the superficial cranial arteries on high-resolution MRI has a pooled sensitivity and specificity of 73% and 88%, respectively. 18 It is important to note that inflammatory involvement of the intracranial arteries is rare compared with extracranial arteries of the head, which may be related to the less elastic tissue composition of these vessels. 25 Contrast-enhanced magnetic resonance angiography (MRA) allows detection of vessel stenosis, occlusions, dilatations, and aneurysms of large vessels with high sensitivity and specificity. 26, 27 Although contrast-enhanced MRA has been shown to have excellent diagnostic accuracy for Takayasu arteritis, it has not been formally studied in GCA. 28 Limited case reports describing use of MRI and MRA in the evaluation of GCA suggest they can be helpful diagnostically. 26, 29 Other advantages of MRI, MRA, computed tomography angiography, and positron emission tomography (PET) imaging modalities are that they produce results that are independent of the technician and observer, are reproducible, and are standardized such that comparisons can be made among studies. 30 The Case for Positron Emission Tomography
Positron emission tomography with 18F fluoro-2-deoxy-D-glucose (FDG) allows assessment of the entire body and can suggest vasculitis in patients with ill-defined systemic symptoms. 1, 4, 18, 29 Aortitis may be present in half of GCA patients, and occult aortitis presenting early in the course of the disease can be detected by FDG-PET. 31, 32 Additionally, FDG-PET or PET/ computed tomography (CT) is useful for the diagnosis of GCA patients who lack temporal artery involvement and present only with vague systemic symptoms such as fatigue, weight loss, or fever. 33 Activated inflammatory cells associated with GCA have an overabundance of glucose transporters, which contributes to higher glucose and FDG uptake and in turn enables early identification of vasculitis with FDG-PET. 33, 34 Analysis of FDG-PET also allows quantitative scoring of vascular intensity by comparing it with blood or liver uptake. 30, 32, 34 For GCA patients in remission, FDG-PET may also be useful for continued monitoring. Grayson and colleagues' 2017 study 34 found that most patients with LVV in remission had FDG-PET results consistent with active vasculitis. Although histologic samples would be necessary to definitively determine if increased FDG uptake in patients in remission denotes vasculitis, hypoxia, tissue remodeling, or atherosclerosis, findings indicate that subclinical vascular inflammation probably accounts for this increased activity on PET. 34 This is supported by the higher incidence of relapse for patients with increased overall FDG uptake during clinical remission. 34 However, the high rate of active vasculitis diagnosed in the control group (composed of patients with conditions similar to LVV) underscores the importance of interpreting FDG-PET results in the context of other clinical factors. 34 
ARGUMENTS AGAINST NONINVASIVE IMAGING The Value of Temporal Artery Biopsy
Temporal artery biopsy is a relatively low-risk, minor procedure that many providers can perform in the clinic setting using local anesthetic. Furthermore, TAB provides definitive histologic evidence of vasculitis and supports clinicians in the decision to initiate long-term corticosteroid treatment for GCA, which includes many inherent risks. 5 Hall and colleagues 35 demonstrated that TAB had a positive predictive value of 94% and Vilaseca and colleagues 36 reported a sensitivity, specificity, and positive predictive value of 81.8%, 100%, and 90.2%, respectively, compared with the final clinical diagnosis of GCA. The classic histologic findings of GCA are transmural granulomatous inflammation and destruction of the internal elastic lamina. 1, 37 In some cases, however, the inflammation is less widespread and follows a pattern of periadventitial small vessel vasculitis (SVV) or vasa vasorum vasculitis (VVV). 37 Therefore, in patients without transmural inflammation, TAB may be a more reliable diagnostic test than noninvasive imaging. 37 The Case Against Ultrasound
Muratore and colleagues 37 questioned the diagnostic certainty of US and its ability to either rule in or rule out GCA. The frequency of the halo sign was only 20% in patients with SVV or VVV compared with 82.5% in patients with classic histological findings of GCA. 37 Interestingly, although these patients had a lower incidence of cranial and constitutional symptoms and lower erythrocyte sedimentation rate and C-reactive protein than patients with classic GCA, the number of cranial ischemic events was similar in both groups. 37 In 2002, Salvarani and colleagues 38 reported that the ultrasonographic halo sign showed a low sensitivity of 40% and a moderate specificity of 79%. The authors concluded that US testing is not sufficiently accurate to replace TAB. 38 In 2005, Karassa and colleagues' meta-analysis 39 showed that the weighted sensitivity and specificity of the halo sign compared with biopsy were 69% and 82%, respectively. These results suggest that absence of the halo sign makes GCA less likely. 40 In 2010, Ball and colleagues 40 revealed that, when compared with TAB, the halo sign had an overall sensitivity and specificity of 75% and 83%, respectively. The authors noted significant heterogeneity among groups within studies and between studies, potentially limiting the reliability and generalizability of the results. 40 Much of this variability results from the operator dependent nature of ultrasonography. Other technical limitations to the implementation of US imaging of the temporal arteries exist. The European League Against Rheumatism advocates the use of high-quality instrumentation including linear probes with B-mode frequency over 15 MHz and image depth of 10-20 mm for temporal arteries. 18 The image must be focused at the level of the temporal artery and the color Doppler mode should be optimized to fill the vessel lumen. 18 A potential pitfall of US evaluation is the variability of exam technique and interpretation among US technicians and physicians, with the tendency to overdiagnose the halo sign. 2, 41 Additionally, the presence of an accompanying vein with slow flow can look like a perivascular hypoechoic region concerning for a halo. 2, 20 The thickness of the ultrasonographic halo is important in determining a positive test, yet it is not standardized among studies. 38 Furthermore, US could miss early stage arteritis occurring before the development of a halo sign. 2, 37 Finally, US cannot identify subtle histologic pathology or discriminate between GCA and other inflammatory conditions such as granulomatosis with polyangitis, polyarteritis nodosa, Churg-Strauss, and primary amyloidosis, which have been reported to cause temporal artery inflammation. 10, 13 In summary, the data and conclusions across the numerous studies examining the diagnostic accuracy and clinical utility create logistical difficulties for patients and providers. 16 Nielsen and colleagues 16 reported a 10-15% reduction in FDG uptake at day 3 and a 30-40% reduction at day 10. This did not alter diagnostic sensitivity at day 3 but reduced the diagnostic sensitivity of PET at day 10. 16 For the routine diagnosis of GCA, EULAR advises against the use of CT and PET due to a lack of evidence, radiation exposure, and high cost. 18 
CONCLUSIONS
Thorough clinical assessment along with noninvasive imaging, TAB, or both provides clinicians the necessary resources to evaluate for GCA. 7 In the absence of a single diagnostic study with sufficient sensitivity and specificity, the diagnosis of GCA continues to rely on a combination of careful clinical evaluation and practical use of ancillary testing.
7,18 Although US is not yet poised to supplant TAB, the literature supports its use in particular scenarios. In patients with low clinical suspicion of GCA, a normal US (assuming high expertise) supports the idea that a patient does not have GCA. 7, 18, 22 Conversely, in a patient with a high pretest probability of GCA and positive halo sign, some providers may choose to forego a TAB given the high specificity of the halo sign. 7, 18, 22, 24 Meanwhile, in a patient with high clinical suspicion for GCA and a negative US, the provider should pursue a TAB because of the lower sensitivity of US (Fig. 3) . Finally, the clinical utility of US in GCA extends beyond simple diagnostic inclusion or exclusion. It could be used to help direct TAB to areas of active inflammation.
In the absence of high-quality US imaging or interpretation, high-resolution MRI represents another noninvasive alternative with reasonable sensitivity and specificity. Considering the high cost and limited accessibility of MRI, US remains preferable if the institution has an experienced ultrasonographer. However, MRI could be used in a similar decision-making paradigm as US (Fig. 3) . In select cases of GCA, PET imaging may be diagnostically useful, but its high cost, limited availability, susceptibility to interference from adjacent brain tissue, and inability to discriminate among a wide spectrum of inflammatory, infectious, and neoplastic disorders limits its clinical utility.
In the future, GCA diagnosis will ideally be made using a noninvasive test with excellent sensitivity and specificity. In the meantime, TAB remains necessary in many cases.
of temporal artery US are inconsistent. Based on these results, ultrasonographic findings cannot be solely relied upon to accurately rule out GCA. However, if there is access to an experienced ultrasonographer, a negative temporal artery US could help rule out GCA if the pretest probability is low. In addition, if a patient has a clinical scenario very suspicious for GCA, a positive temporal artery US could alleviate the need for TAB for some providers because these patients would likely be treated with corticosteroids even if the TAB was negative.
The Case Against Magnetic Resonance Imaging
Despite the excellent sensitivity and specificity (80.6% and 97.0%, respectively) of high-resolution MRI, 4 logistics including high cost and limited availability restrict its use in the diagnosis of GCA. 8 Additionally, high-resolution MRI scans require use of a specialized technique with multiple coils and an extended scan duration. 18 To avoid false-negative MRI results, the scan should be performed soon after initiation of corticosteroids. 18, 42 Hauenstein and colleagues 42 recommend performing US and MRI testing within 1 day of starting corticosteroid treatment. Compared with final diagnosis of GCA, the sensitivity of MRI performed within 1 day of corticosteroid initiation was 85% and decreased to 56% after more than 4 days of steroid treatment. 42 In contrast, though corticosteroid treatment also affects histological findings on TAB, the diagnostic value is not significantly affected over this short time period. 42 The Case Against Positron Emission Tomography Similar to MRI, PET has practical clinical limitations including high expense, limited availability, and insurance approval only for workup of neoplastic conditions. 29 The low spatial resolution of PET limits its usefulness to evaluation of vessels larger than 2 mm. 4 In addition, FDG uptake in superficial cranial vessels cannot be reliably distinguished from nearby brain tissue due to high physiologic glucose metabolism in the brain. 18, 29 Furthermore, FDG-PET results are often nonspecific as elevated uptake occurs in a variety of clinical scenarios such as osteomyelitis, colitis, sarcoidosis, tuberculosis, thyroiditis, Takayasu arteritis, and polymyalgia rheumatica. 29 The narrow diagnostic window of FDG-PET in patients with suspected GCA who have been started on high-dose corticosteroids is also relevant because it necessitates prompt imaging after treatment initiation and may
